TTK Healthcare Signs Definitive Agreement to Sell EVA and Good Home Brands to Wipro Enterprises for ₹256 Crore

On July 23, 2026, TTK Healthcare Limited announced the sale of its EVA and Good Home brands to Wipro Enterprises Private Limited, as per the exchange filings.  

The transaction, valued at ₹256 crore plus applicable GST, was approved by the Board of Directors on July 23, 2026. 

Details of the Transaction 

The definitive agreements for the sale were signed on July 23, 2026. The completion of the transaction is subject to customary conditions precedent, with an expected closing date of September 30, 2026.  

The brands contributed ₹148 crore, or 17%, to TTK Healthcare's total turnover in FY 2025-26. 

Buyer Information 

Wipro Enterprises Private Limited is the buyer in this transaction. It is not part of TTK Healthcare's promoter group, and the sale does not fall under related party transactions. The transaction is conducted outside a scheme of arrangement and is not classified as a slump sale. 

Read More: Wipro Consumer Care to Acquire Philippines Based S Brands in 16th Global Acquisition! 

Financial Considerations 

The total consideration for the sale is ₹256 crore. The transaction is structured to ensure compliance with relevant regulations, including SEBI's guidelines on disclosure requirements. This move aligns with TTK Healthcare's strategic decisions to streamline its brand portfolio. 

TTK Healthcare Share Price Performance 

As of July 23, 2026, at 3:30 PM, TTK Healthcare share price on NSE was closed at ₹1,012.55, up by 0.65% from the previous closing price. 

Conclusion 

TTK Healthcare's sale of EVA and Good Home brands to Wipro Enterprises for ₹256 crore represents 17% of its FY 2025-26 turnover. The transaction is set to close by September 30, 2026, pending customary conditions. 

Track the stock market in Hindi. Visit Angel One News for the latest market trends, insights, and share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.